Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01649869
Recruitment Status : Recruiting
First Posted : July 25, 2012
Last Update Posted : April 3, 2018
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 27, 2019
  Estimated Study Completion Date : February 1, 2020